Globes: Teva to pay $250m to settle Propofol suits
Published on Feb 22 2012 // Business and Financial News
February 22, 2012–Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) will be forced to pay over $250 million to settle more than 80 lawsuits filed against it relating to the anesthetic Propofol. The claims against Teva charge that Propofol was allegedly deliberately sold in vials large enough to be reused by doctors, resulting in patients in Las Vegas undergoing colonoscopy procedures developing hepatitis C.
Teva reportedly agreed last week to resolve the claims, according to sources close to the litigation…Read More>>
